Eam Global Investors LLC Arcus Biosciences, Inc. Transaction History

Eam Global Investors LLC

  • $435 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$28.92 - $41.83 $1.43 Million - $2.07 Million
-49,498 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$31.38 - $48.47 $1.55 Million - $2.4 Million
49,498 New
49,498 $2 Million
Q3 2020

Nov 13, 2020
SELL
$17.14 - $25.47 $632,723 - $940,225
-36,915 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$13.97 - $36.56 $515,702 - $1.35 Million
36,915 New
36,915 $913,000

Others Institutions Holding RCUS

# of Institutions
200
Shares Held
51.5M
Call Options Held
236K
Put Options Held
141K
View Full List

About Arcus Biosciences, Inc.

RCUS Quotes by TradingView
  • Ticker RCUS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 72,160,000
  • Market Cap $1.02B
  • Description
  • Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...
More about RCUS
Track This Portfolio

Track Eam Global Investors LLC Portfolio

Follow Eam Global Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email